Inventor · disambiguated record
Charlene F. Barroga
Also filed as: BARROGA CHARLENE F
16 granted patents·5 pending applications·110 citations·filing 2009–2021
94Inventor score
Top patents by PatentIndex Score
21 records- 0196US9795550B2Gamma-diketones for treatment and prevention of aging skin and wrinklesSAMUMED LLC·Filed 2015·Granted Oct 24, 2017·12 cites·38 claims
- 0295US8629176B1β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Jan 14, 2014·17 cites·14 claims
- 0394US10434052B2Gamma-diketones for treatment and prevention of aging skin and wrinklesSAMUMED LLC·Filed 2017·Granted Oct 8, 2019·3 cites·18 claims
- 0494US8921413B2β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Dec 30, 2014·14 cites·15 claims
- 0593US9884053B2β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2016·Granted Feb 6, 2018·7 cites·42 claims
- 0693US9303010B2β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Apr 5, 2016·12 cites·11 claims
- 0792US8609717B2β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activatorsKC SUNIL KUMAR·Filed 2011·Granted Dec 17, 2013·17 cites·16 claims
- 0891US9493437B2β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Nov 15, 2016·8 cites·17 claims
- 0990US9533976B2γ-diketones as WNT/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Jan 3, 2017·9 cites·3 claims
- 1089US11673885B2γ-diketones as Wnt/β-catenin signaling pathway activatorsBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jun 13, 2023·1 cites·17 claims
- 1189US10314832B2β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2017·Granted Jun 11, 2019·4 cites·33 claims
- 1286US10457672B2γ-diketones as Wnt/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2018·Granted Oct 29, 2019·3 cites·8 claims
- 1385US11077046B2Gamma-diketones for treatment and prevention of aging skin and wrinklesBIOSPLICE THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·1 cites·11 claims
- 1484US11034682B2Gamma-diketones as wnt/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2019·Granted Jun 15, 2021·1 cites·10 claims
- 1578US2020121663A1B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORSSAMUMED LLC·Filed 2019·Application pending·0 cites
- 1677US9951053B2γ-diketones as Wnt/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2016·Granted Apr 24, 2018·1 cites·22 claims
- 1776US11839679B2Gamma-diketones for treatment and prevention of aging skin and wrinklesBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·16 claims
- 1876US2021353604A1ß- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ ß -CATENIN SIGNALING PATHWAY ACTIVATORSBIOSPLICE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1949US2009286246A1Methods for Identifying Compounds that Affect Expression of Cancer-Related Protein IsoformsWINTHERIX LLC·Filed 2009·Application pending·0 cites
- 2049US2010068708A1Methods for Identifying Compounds that Modulate WNT Signaling in Cancer CellsWINTHERIX LLC·Filed 2009·Application pending·0 cites
- 2146US2023000842A1Methods of treating cartilage disorders through inhibition of clk and dyrkSAMUMED LLC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →